- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06001918
Studio clinico del sistema Nectero EAST (stAAAble)
Sperimentazione clinica controllata randomizzata (RCT) del sistema Nectero EAST per la stabilizzazione degli aneurismi dell'aorta addominale di piccole e medie dimensioni (AAA): valutazione dell'efficacia.
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Fase 2
- Fase 3
Contatti e Sedi
Contatto studio
- Nome: Charlene Knape
- Numero di telefono: 866-755-4744
- Email: cknape@necteromedical.com
Backup dei contatti dello studio
- Nome: Tracy Roberts
- Numero di telefono: (303)3964603
- Email: troberts@necteromedical.com
Luoghi di studio
-
-
New South Wales
-
Randwick, New South Wales, Australia, 2031
- Reclutamento
- Prince of Wales Private Hospital- POW Vascular Institute
-
Investigatore principale:
- Ramon Varcoe
-
Contatto:
- Jade Goh
- Numero di telefono: 04 87 369 396
- Email: pow.vascular.institute@gmail.com
-
-
-
-
-
Auckland, Nuova Zelanda, 1023
- Reclutamento
- Auckland City Hospital
-
Contatto:
- Cynthia Corne
- Numero di telefono: 21505 +64 9 307 4949
- Email: CorneC@adhb.govt.nz
-
Investigatore principale:
- Andrew Holden, A/Prof
-
-
-
-
Arizona
-
Scottsdale, Arizona, Stati Uniti, 85258
- Reclutamento
- Honor Health Scottsdale Shea Medical Center
-
Investigatore principale:
- Hasan Aldailami, MD
-
Contatto:
- HonorHealth Cardiovascular Research
- Numero di telefono: 480-323-1046
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80045
- Attivo, non reclutante
- University of Colorado
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stati Uniti, 20010
- Reclutamento
- Medstar Washington Hospital Center
-
Investigatore principale:
- Steven Abramowitz, MD
-
Contatto:
- Kassaye Sesaba, MD
- Numero di telefono: 202-877-7452
- Email: Kassaye.T.Sesaba@medstar.net
-
Contatto:
- Suman Singh, MD
- Numero di telefono: (202) 877-8475
- Email: Suman.Singh@Medstar.net
-
-
Florida
-
Delray Beach, Florida, Stati Uniti, 33446
- Reclutamento
- Prime Vascular Institute
-
Investigatore principale:
- Joseph Ricotta, MD
-
Contatto:
- Jordan Sprechman
- Numero di telefono: 561-495-3145
- Email: Jordan.Sprechman@tenethealth.com
-
Contatto:
- Alexia Medick
- Email: Alexia.Medick@tenethealth.com
-
-
Georgia
-
Augusta, Georgia, Stati Uniti, 30912
- Reclutamento
- Medical College of Georgia
-
Investigatore principale:
- William Jordan, MD
-
Contatto:
- Natasha Flores
- Email: nflores@augusta.edu
-
Contatto:
- Candelario Laserna
- Numero di telefono: 706-721-2199
- Email: calaserna@augusta.edu
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60637
- Reclutamento
- University of Chicago
-
Contatto:
- MacKenton Johnson
- Numero di telefono: 773-795-3639
- Email: mackenton@bsd.uchicago.edu
-
Investigatore principale:
- Ross Milner, MD
-
Elk Grove, Illinois, Stati Uniti, 60007
- Non ancora reclutamento
- Ascension Alexian Brothers
-
Investigatore principale:
- Jack Chamberlin, MD
-
-
Maine
-
Scarborough, Maine, Stati Uniti, 04074
- Reclutamento
- MaineMed Vascular Surgery
-
Investigatore principale:
- Kristina Giles, MD
-
Contatto:
- Kathryn Ackermann
- Email: kathryn.ackermann@mainehealth.org
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02114
- Reclutamento
- Massachusetts General Hospital
-
Investigatore principale:
- Nikolaos Zacharias, MD
-
Contatto:
- Bonnie Chen
- Email: BCHEN13@mgh.harvard.edu
-
Boston, Massachusetts, Stati Uniti, 02215
- Reclutamento
- Beth Israel Deaconess Medical Center
-
Investigatore principale:
- Marc Schermerhorn, MD
-
Contatto:
- Monica Goyal
- Numero di telefono: 617-632-7534
- Email: mgoyal@bidmc.harvard.edu
-
Contatto:
- Fernando Moreno
- Email: fmoreno@bidmc.harvard.edu
-
Worcester, Massachusetts, Stati Uniti, 01655
- Reclutamento
- University of Massachusetts
-
Contatto:
- Shauneen Valliere
- Email: shauneen.valliere@umassmed.edu
-
Investigatore principale:
- Andres Schanzer, MD
-
-
Michigan
-
Royal Oak, Michigan, Stati Uniti, 48073
- Reclutamento
- Beaumont Health
-
Investigatore principale:
- Graham Long, MD
-
Contatto:
- Lisa Bliss
- Email: lisa.bliss@corewellhealth.org
-
-
Missouri
-
St Louis, Missouri, Stati Uniti, 63110
- Reclutamento
- Washington University School of Medicine
-
Investigatore principale:
- Luis Sanchez, MD
-
Contatto:
- Briana K Langrehr, BSN
- Email: briana.l@wustl.edu
-
-
Nebraska
-
Omaha, Nebraska, Stati Uniti, 68198
- Reclutamento
- University of Nebraska Medical Center
-
Investigatore principale:
- Jonathan Thompson, MD
-
Contatto:
- Jarod Phillips
- Email: jarphillips@unmc.edu
-
-
New Hampshire
-
Lebanon, New Hampshire, Stati Uniti, 03766
- Reclutamento
- Dartmouth Hitchcock Medical Center
-
Investigatore principale:
- Rebecca Scully, MD
-
Contatto:
- Pauline Sirrell
- Email: pauline.sirrell@hitchcock.org
-
-
New York
-
Rochester, New York, Stati Uniti, 14642
- Reclutamento
- University of Rochester
-
Contatto:
- Mary Bourret
- Email: Mary_Bourret@URMC.Rochester.edu
-
Investigatore principale:
- Doran Mix, MD
-
Stony Brook, New York, Stati Uniti, 11794
- Non ancora reclutamento
- Stony Brook Medicine
-
Investigatore principale:
- Rabih Chaer, MD
-
Contatto:
- Daria Shavarina
- Email: Daria.Shavarina@stonybrookmedicine.edu
-
-
North Carolina
-
Durham, North Carolina, Stati Uniti, 27710
- Reclutamento
- Duke University Medical Center
-
Investigatore principale:
- Chandler Long, MD
-
Contatto:
- Ellen Burkett
- Numero di telefono: (919)681-1878
- Email: ellen.jones@duke.edu
-
-
Ohio
-
Cincinnati, Ohio, Stati Uniti, 45219
- Reclutamento
- The Christ Hospital
-
Contatto:
- Jamie Elkins
- Email: Jamie.Elkins@thechristhospital.com
-
Investigatore principale:
- Geoff Answini, MD
-
Cleveland, Ohio, Stati Uniti, 44106
- Reclutamento
- University Hospitals Cleveland
-
Investigatore principale:
- Jae Cho, MD
-
Contatto:
- Amy Kluge
- Email: Amy.Kluge@UHhospitals.org
-
Cleveland, Ohio, Stati Uniti, 44195
- Reclutamento
- Cleveland Clinic
-
Investigatore principale:
- Francis Caputo, MD
-
Contatto:
- Laurie Ann Moennich
- Email: MOENNIL@ccf.org
-
Columbus, Ohio, Stati Uniti, 43210
- Reclutamento
- The Ohio State University Wexner Medical Center
-
Contatto:
- Subh Das
- Numero di telefono: 614-366-6596
- Email: subhashish.das@osumc.edu
-
Investigatore principale:
- Kristine Orion, MD
-
Columbus, Ohio, Stati Uniti, 43214
- Reclutamento
- Ohio Health Riverside
-
Investigatore principale:
- Joseph Campbell, MD
-
Contatto:
- Regan Moran
- Email: Regan.Moran@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Stati Uniti, 74104
- Reclutamento
- Oklahoma Heart Institute
-
Investigatore principale:
- Julia Chen, MD
-
Contatto:
- Tia Whitaker
- Email: Tia.Whitaker@hillcrest.com
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97239
- Reclutamento
- Portland VA Medical Center
-
Investigatore principale:
- Matthew Koopmann, MD
-
Contatto:
- Rachel Nelson
- Email: Rachel.Nelson1@va.gov
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Stati Uniti, 18015
- Reclutamento
- St. Luke's University Health Network
-
Investigatore principale:
- Sharvil Sheth, MD
-
Contatto:
- Jena Hagerty
- Numero di telefono: 484-658-4982
- Email: Jena.Hagerty@sluhn.org
-
Philadelphia, Pennsylvania, Stati Uniti, 19104
- Reclutamento
- Hospital of the University of Pennsylvania
-
Contatto:
- Carolina Reyes
- Numero di telefono: 215-615-8036
- Email: carolina.reyes1@pennmedicine.upenn.edu
-
Investigatore principale:
- Grace Wang, MD
-
Philadelphia, Pennsylvania, Stati Uniti, 19107
- Reclutamento
- Jefferson Clinical Research Institute
-
Contatto:
- Jona Shperdheja
- Email: Jona.Shperdheja@jefferson.edu
-
Investigatore principale:
- Michael Nooromid, MD
-
Pittsburgh, Pennsylvania, Stati Uniti, 15219
- Reclutamento
- University of Pittsburgh Medical Center
-
Contatto:
- Judith Brimmeier
- Email: brimmeierja@upmc.edu
-
Investigatore principale:
- Raymond Eid, MD
-
-
South Carolina
-
Greenville, South Carolina, Stati Uniti, 29605
- Reclutamento
- Prisma Health
-
Investigatore principale:
- Mark P Androes, MD
-
Contatto:
- Nikita Kasinger
- Email: Nikita.Kasinger@PrismaHealth.org
-
Contatto:
- Maggie Salle
- Email: Margaret.Salle@PrismaHealth.org
-
-
South Dakota
-
Sioux Falls, South Dakota, Stati Uniti, 57108
- Reclutamento
- North Central Heart - A Division of Avera Heart Hospital
-
Investigatore principale:
- Michael Bacharach, MD
-
Contatto:
- Patty Eisenbraun, RN
- Numero di telefono: 605-977-5336
- Email: peisenbraun@ncheart.com
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37232
- Reclutamento
- Vanderbilt University Medical Center
-
Investigatore principale:
- John Curci, MD
-
Contatto:
- Celia Nunez
- Email: celia.m.nunez@vumc.org
-
Contatto:
- Jennifer Scott
- Email: jennifer.scott@vumc.org
-
Nashville, Tennessee, Stati Uniti, 37212
- Non ancora reclutamento
- VA Tennessee Valley Healthcare System
-
Investigatore principale:
- John Curci, MD
-
Contatto:
- Sohpia Miner
- Email: Sophia.Miner@va.gov
-
-
Texas
-
Houston, Texas, Stati Uniti, 77004
- Reclutamento
- Houston Healthcare
-
Investigatore principale:
- Kristofer Charlton-Ouw, MD
-
Contatto:
- Swathi Potla
- Email: swathi.potla@hcahealthcare.com
-
Plano, Texas, Stati Uniti, 75093
- Reclutamento
- Baylor Scott & White Medical Center
-
Investigatore principale:
- William Shutze, MD
-
Contatto:
- Saba Arianpour
- Email: Saba.Arianpour@BSWHealth.org
-
-
Utah
-
Salt Lake City, Utah, Stati Uniti, 84132
- Reclutamento
- University of Utah Hospital
-
Contatto:
- Julie Hales
- Email: Julie.Hales@hsc.utah.edu
-
Investigatore principale:
- Cali Johnson, MD
-
-
Virginia
-
Fairfax, Virginia, Stati Uniti, 22031
- Reclutamento
- Inova Fairfax Medical Campus Inova Health Systems
-
Contatto:
- Bhruga Shah
- Email: Bhruga.shah@inova.org
-
Investigatore principale:
- Kendal Endicott, MD
-
Norfolk, Virginia, Stati Uniti, 23507
- Reclutamento
- Sentara Health
-
Investigatore principale:
- David Dexter, MD
-
Contatto:
- Angela Zahn
- Email: AXZAHN@sentara.com
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98104
- Reclutamento
- University of Washington at Harborview Medical Center
-
Contatto:
- Allison Larimore
- Email: alari@uw.edu
-
Investigatore principale:
- Benjamin Starnes, MD
-
-
Wisconsin
-
Green Bay, Wisconsin, Stati Uniti, 54301
- Reclutamento
- Bellin Memorial Hospital
-
Investigatore principale:
- Jason Ricci, MD
-
Contatto:
- Katie Guilliams
- Email: Katherine.Guilliams@emplifyhealth.org
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Males and females ≥21 to ≤85 years of age. Females must be of non-childbearing potential (menopause or sterilization).
- Subject understands the purpose of the trial, agrees to voluntarily participate in the trial, signs the informed consent and is willing to complete the follow-up according to the requirements of the protocol.
- Infrarenal atherosclerotic fusiform abdominal aortic aneurysm from 3.5 cm to 5.0 cm (male) and 3.5 cm to 4.5 cm (female).
- Infrarenal aortic neck ≥ 15 mm in length and ≤ 29 mm in diameter.
- Overall AAA treatment length (distal renal to distal inferior margin of the aneurysm) not to exceed 130 mm.
- Iliac and femoral artery access, vessel size and morphology allow endovascular access of 14F (or larger) introducer sheaths and catheters.
- Subject meets American Society of Anesthesiology (ASA) grade 1 through 3 criteria, inclusive.
- Subject has > three-year life expectancy.
- Subject is able and willing to comply with all required follow-up clinic visits including CT scans (pre-randomization, 6, 12, 18, 24 months and annually up to 5 years) and blood draws.
Exclusion Criteria:
- Subject has an acutely ruptured, leaking, dissecting or emergent aneurysm.
- Subject has a symptomatic infrarenal abdominal aortic aneurysm.
- Subject has a mycotic or infected aneurysm.
- Subject has current vascular injury due to trauma.
- Subject's aneurysm is thoracic, suprarenal or juxtarenal.
- Previous surgical or endovascular aneurysm repair for abdominal aortic aneurysm.
- Subject has anatomy of diffuse, ulcerated, or extensive (shaggy) thrombus in the neck of the AAA, that in the opinion of the vascular surgeon/investigator, could result in embolization of the thrombus.
- Subject has anatomy of calcification, and/or plaque within the ilio-femoral arteries or severe infrarenal neck angulation that may compromise or does not allow delivery of the Introducer Sheath or the delivery catheter of the Nectero EAST System.
- Subject has had a myocardial infarction within six (6) months prior to enrollment or elevated CK enzymes or troponin indicative of an evolving MI prior to procedure.
- Subject has current angina, unstable angina, or other active cardiac condition such as congestive heart failure III and IV, atrial arrhythmia, ventricular arrhythmia, or valvular disease, requiring intervention.
- Subject has undergone other major surgery within the 30 days prior to enrollment.
- Subjects with any transient ischemic attack (TIA) or ischemic stroke within 3 months.
- Known allergy to contrast material that cannot be adequately premedicated, delivery system materials (i.e., nylon, polyurethane) and/or pentagalloylglucose (PGG).
- Subject is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.
- Subject has connective tissue/collagen disorder (e.g., Marfan syndrome, vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Eaton Syndrome, Bessel-Hagen disease, etc.).
- Known contraindication to undergoing angiography or receiving systemic anticoagulation during the procedure.
- Subject has active systemic infection.
- Subject is participating in another research trial that could interfere with the results of the trial (e.g., drug trial).
- Subject has other medical, social, or psychological problems that, in the opinion of the investigator, preclude them from participation in the trial and to undergo the procedures and evaluations pre- and post-treatment.
- Subject has dialysis dependent renal failure or baseline serum creatinine level >2.5mg/dL or eGFR < 45 mL/min/1.73m2.
- Subjects with aminotransferase (ALT and/or AST) which is ≥1.5x upper limit of normal (ULN) or TB that is our of normal range for the evaluating laboratory.
- Subjects that may not tolerate the lowering of their systolic blood pressure to approximately 100mmHg, should not be considered for this study or treated using the Nectero EAST System.
- Subjects that may not be able to tolerate transient occlusion of the aorta should not be considered for this study.
- Subjects with saccular AAA.
- Subjects with rapidly expanding AAA (previous diameter increases of ≥0.5 cm in 6-months or ≥1 cm in 1 year) as these should be evaluated for immediate repair.
- Subjects who are not suitable for the Nectero EAST System treatment, as determined by the investigator.
- Subjects with INR out of normal range for the evaluating laboratory for a subject not on anti-coagulant therapy; or INR >3 for a subject on anti-coagulant therapy.
- Subjects with active/acute or a history of unstable chronic liver disease or current liver disease including but not limited to liver transplant, known genetic disorders such as Gilbert syndrome or other liver diseases.
- Subjects with cirrhosis (e.g., known history or new clinical diagnosis by elastography with a fibrosis score of F3 or F4 and/or steatosis grade of S3).
- Subjects with uncontrolled alcohol use disorder or current alcohol use putting them at risk of liver disease: including consumption of above one standard drink per day for women and two standard drinks per day for men.
- Subjects with known right-sided heart failure or pathologically dilated inferior vena cava or hepatic veins indicative of congestive hepatopathy.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Treatment Arm
Participants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer |
Treated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug. |
|
Nessun intervento: Control Arm
Participants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Primary Endpoint
Lasso di tempo: 24 months
|
The primary endpoint is the composite of all AAA-related death, rupture and repair (open-surgical, EVAR, or clinically indicated for repair as adjudicated by a committee of clinical experts blinded to the assigned arm). |
24 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Growth
Lasso di tempo: 24 months
|
The growth over time in aneurysm diameter based on CT core laboratory readings. |
24 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Daniel Clair, MD, Vanderbilt University Medical Center
- Investigatore principale: Grace Wang, MD, University of Pennsylvania
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- EAST002
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .